StockIQ.techAbbVie Inc. (ABBV) Stock Analysis
Free AI-powered analysis and research for AbbVie Inc. stock
Sector: Healthcare
ABBV snapshot
Data as of 16 Oct 2026 close. Updated daily.
AbbVie Inc. scores 55/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 94% of its 52-week range, up 24.3% over the past year. Latest reported figures show a profit margin of 9.8% and revenue growth of +10.2%.
What is driving the score
- RSI Overbought: -15
- Strong Uptrend: +12
- MACD Bullish: +8
- High P/E (79.4): -10
- Low Liquidity (0.81 Current Ratio): -10
- Low P/B (-83.69): +5
- Strong Long-term Uptrend: +8
- Healthy Momentum (+24.3% over 1 year): +7
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ABBV report
AbbVie Inc. (ABBV) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ABBV Now →📰 Latest Update
Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends
Fri, October 16, 2026 at 9:48 PM UTC 4 min read
AbbVie has been highlighted for its attractive dividend yield, prompting discussions on how many shares an investor would need to hold in order to generate $5,000 in annual dividends. This information is significant for income-focused investors, as it underscores AbbVie's commitment to returning value to shareholders through consistent dividend payments. Understanding the share quantity required for substantial dividend income can aid investors in making informed decisions about their portfolios.